ORBIMED ADVISORS LLC Q4 2025 Filing
Filed February 17, 2026
Portfolio Value
$4.9T
Holdings
105
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (105 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | OCULOCULAR THERAPEUTIX INC | 157,300 | $1.9B | 0.04% | |
| 102 | PTGXPROTAGONIST THERAPEUTICS INC | 21,700 | $1.9B | 0.04% | |
| 103 | PTCTPTC THERAPEUTICS INC | 23,200 | $1.8B | 0.04% | |
| 104 | COGTCOGENT BIOSCIENCES INC | 1,000,000 | $1.2B | 0.02% | |
| 105 | MPLTMAPLIGHT THERAPEUTICS INC | 56,000 | $952.0M | 0.02% | |
| 106 | TRAWTRAWS PHARMA INC | 605,531 | $684.0M | 0.01% |
PreviousPage 2 of 2